Deprescribing of cardiometabolic drugs was deemed relevant by healthcare providers from all disciplines but its implementation needs further support.

Not all healthcare professionals have adopted a proactive deprescribing approach, which is needed to prevent adverse drug events in older and frail patients.

Good communication with patients and relatives was considered essential for deprescribing cardiometabolic medication, with some healthcare providers needing training to improve their skills to do so.

A multidisciplinary approach with agreements on information exchange and task delegation can be recommended given the perceived barriers and enablers for deprescribing.